Literature DB >> 15820769

Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities.

Caroline D Souza-Tarla1, Juliana A Uzuelli, Alcyone A Machado, Raquel F Gerlach, Jose E Tanus-Santos.   

Abstract

OBJECTIVES: To examine whether a linear relationship exists between the volume of plasma loaded in each gel lane and the gelatinolytic activities of plasma matrix metalloproteinase (pMMP)-2 and pMMP-9, and the influences of plasma storage temperature, fasting, and a variable number of repeated freeze-thaw cycles. DESIGN AND METHODS: Plasma from venous blood collected into EDTA tubes was stored for 1 month at -20 degrees C or at -70 degrees C until assayed for gelatin zymography of pMMP-2 and pMMP-9. The effects of food intake, repeated freeze-thaw cycles, and the gelatinolytic activity produced by serial dilutions of plasma were examined.
RESULTS: Storage temperature, fasting, and up to five repeated freeze-thaw cycles had no effect on the activities of pMMPs (all P < 0.05). A linear relationship was found with plasma volumes below 0.75 microL/lane for MMP-2, and from 0.75 microL/lane to 2 microL/lane for MMP-9.
CONCLUSIONS: Different volumes of plasma should be studied when pMMP-2 and pMMP-9 activities are studied. Storage temperature, repeated freeze-thaw cycles, and food intake do not affect the activities of pMMPs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15820769     DOI: 10.1016/j.clinbiochem.2005.02.010

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  21 in total

1.  Combining two potential causes of metalloproteinase secretion causes abdominal aortic aneurysms in rats: a new experimental model.

Authors:  Karina M Mata; Paula S Prudente; Fabio S Rocha; Cibele M Prado; Elaine M Floriano; Jorge Elias; Elen Rizzi; Raquel F Gerlach; Marcos A Rossi; Simone G Ramos
Journal:  Int J Exp Pathol       Date:  2010-10-29       Impact factor: 1.925

2.  Plasma matrix metalloproteinase-9 response to eccentric exercise of the elbow flexors.

Authors:  Molly C Madden; William C Byrnes; Jacob A Lebin; Matthew E Batliner; David L Allen
Journal:  Eur J Appl Physiol       Date:  2011-01-11       Impact factor: 3.078

3.  Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas.

Authors:  Fabio M Iwamoto; Andreas F Hottinger; Sasan Karimi; Elyn Riedel; Jocelynn Dantis; Maryam Jahdi; Katherine S Panageas; Andrew B Lassman; Lauren E Abrey; Martin Fleisher; Lisa M Deangelis; Eric C Holland; Adília Hormigo
Journal:  J Neurooncol       Date:  2011-06-28       Impact factor: 4.130

4.  Nitric oxide attenuates matrix metalloproteinase-9 production by endothelial cells independent of cGMP- or NFκB-mediated mechanisms.

Authors:  Cesar A Meschiari; Tatiane Izidoro-Toledo; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  Mol Cell Biochem       Date:  2013-03-03       Impact factor: 3.396

5.  Effect of metabolic syndrome risk factors and MMP-2 genetic variations on circulating MMP-2 levels in childhood obesity.

Authors:  Vanessa A Belo; Marcelo R Luizon; Patrícia C Carneiro; Valéria A Gomes; Riccardo Lacchini; Carla M M Lanna; Debora C Souza-Costa; Jose E Tanus-Santos
Journal:  Mol Biol Rep       Date:  2012-12-16       Impact factor: 2.316

6.  Sodium nitrite attenuates MMP-9 production by endothelial cells and may explain similar effects of atorvastatin.

Authors:  Cesar A Meschiari; Lucas C Pinheiro; Danielle A Guimaraes; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-11-28       Impact factor: 3.000

7.  The Sample Type used Affects the Levels of Gelatinases (MMP-2 and -9) and their Inhibitors (TIMP-1 and -2) in Circulating Blood of Healthy Controls and Breast Cancer Patients.

Authors:  Kuvaja Paula; Talvensaari-Mattila Anne; Turpeenniemi-Hujanen Taina
Journal:  Biomark Insights       Date:  2007-04-03

8.  Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles.

Authors:  Klaus Jung; Ferdinando Mannello; Michael Lein
Journal:  J Transl Med       Date:  2009-10-14       Impact factor: 5.531

9.  Pre-treatment gelatinases' serum levels and post-treatment changes in laryngeal cancer patients.

Authors:  G Tsiropoulos; T Papadas; Ie Triantaphyllidou; S Naxakis; K Markou; S Triaridis; I Vital; P Goumas; Dh Vynios
Journal:  Hippokratia       Date:  2013-07       Impact factor: 0.471

10.  Relation of matrix metalloproteinase-9 to different stages of tumors in the serum of gastric cancer.

Authors:  V Dragutinović; L Izrael-Zivković; N Radovanović
Journal:  Dig Dis Sci       Date:  2008-08-23       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.